US42328V6039 - Common Stock - After market: 0.275 +0 (+0.73%)
NASDAQ:HSDT (12/9/2022, 7:00:02 PM)+0.01 (+2.02%)
|GICS Sector||Health Care|
|GICS Industry||Health Care Equipment & Supplies|
|Earnings (Last)||11-14 2022-11-14/bmo||Earnings (Next)||03-13 2023-03-13|
|Ins Owners||0.15%||Inst Owners||2.9%|
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find more growth stocks the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania. The company went IPO on 2014-06-27. The firm focuses on developing, licensing or acquiring non-implanted technologies targeted at reducing symptoms of neurological disease or trauma. The firm's product, Portable Neuromodulation Stimulator (PoNS), is a non-implanted medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS is used as a short-term treatment of gait deficit due to mild-to-moderate symptoms for multiple sclerosis (MS) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. The company is also used as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy (PoNS Therapy).
HELIUS MEDICAL TECHNOLOGIES
642 Newtown Yardley Road
Newtown PENNSYLVANIA 18940
CEO: Dane C. Andreeff
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!
-- Total Q3 revenue up 80% over prior year ---- Cash on hand expected to fund operations through 2023 ---- Company to host call at 8:30am today -- ...
-- Fourth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects’...
-- Third Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’...
Here you can normally see the latest stock twits on HSDT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.